Baloxavir safety and clinical and virologic outcomes in influenza virus-infected pediatric patients by age group: age-based pooled analysis of two pediatric studies conducted in japan

HIGHLIGHTS

• who: Nobuo Hirotsu from the in Japan have published the article: Baloxavir safety and clinical and virologic outcomes in influenza virus-infected pediatric patients by age group: age-based pooled analysis of two pediatric studies conducted in Japan, in the Journal: (JOURNAL) of 15/Dec/2017
• what: This study assessed safety clinical and virologic outcomes of baloxavir marboxil (baloxavir) treatment in children based on age and influenza virus type/subtype. The aim of this post hoc pooled analysis of influenza virus-infected children from two open-label baloxavir studies was to show for the first . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.